Furthermore, research has demonstrated that genetic predisposition plays a critical role in NAFLD susceptibility, with variants in genes such as MTARC1 being closely associated with an increased risk of NAFLD and its progression to NASH (15). The gene discussed is MTARC1; the disease is metabolic dysfunction-associated steatotic liver disease.